Comparative analysis of cardiac function before LVAD implantation in patients with and without early, acute right heart failure: insights from cardiac magnetic resonance.

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Frontiers in Cardiovascular Medicine Pub Date : 2025-09-24 eCollection Date: 2025-01-01 DOI:10.3389/fcvm.2025.1629252
Carl-Thaddäus Braun, Hermann Körperich, Michiel Morshuis, Sabina P W Guenther, Lech Paluszkiewicz, Nikolai Hulde, Henrik Fox, Sebastian V Rojas, Jan Gummert, René Schramm
{"title":"Comparative analysis of cardiac function before LVAD implantation in patients with and without early, acute right heart failure: insights from cardiac magnetic resonance.","authors":"Carl-Thaddäus Braun, Hermann Körperich, Michiel Morshuis, Sabina P W Guenther, Lech Paluszkiewicz, Nikolai Hulde, Henrik Fox, Sebastian V Rojas, Jan Gummert, René Schramm","doi":"10.3389/fcvm.2025.1629252","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Early acute right heart failure (eaRHF) during left ventricular assist device (LVAD) implantation significantly impacts patient survival and complicates perioperative management. Although numerous clinical, echocardiographic, and hemodynamic risk factors have been identified, accurately predicting eaRHF remains challenging. Cardiac magnetic resonance (CMR) provides a precise, non-invasive evaluation of cardiac structure and function and may enhance risk stratification eaRHF. This study aims to assess the predictive value of preoperative CMR-derived parameters, comparing their utility to established echocardiographic and right heart catheterization (RHC) markers for identifying eaRHF.</p><p><strong>Methods: </strong>This retrospective analysis was conducted on 55 patients who received CMR before LVAD implantation at our center between 2018 and 2024. Of these 55 patients, 40 had image quality sufficient for offline analysis. Patients receiving a temporary right ventricular assist device (tRVAD) intraoperatively were defined as having eaRHF. Receiver Operating Characteristic (ROC) analysis was used to evaluate the predictive capability of CMR, echocardiographic, and RHC parameters.</p><p><strong>Results: </strong>Ten patients (25%) developed eaRHF. Preoperative bilirubin levels were significantly higher in the eaRHF group (1.6 mg/dl vs. 1.1 mg/dl, <i>p</i> = 0.010). Echocardiographic Tricuspid Annular Plane Systolic Excursion (TAPSE) tended to be lower in eaRHF patients (12 mm vs. 18 mm, <i>p</i> = 0.080). RHC parameters, specifically right ventricular stroke work index (RV-SWI; <i>p</i> < 0.001), cardiac output (CO; <i>p</i> = 0.003), and cardiac index (CI; <i>p</i> = 0.004), were significantly lower in eaRHF patients. CMR showed significantly higher RV end-diastolic volumes (RV-EDV, 288.4 ml vs. 216.7 ml, <i>p</i> = 0.046) and indexed RV-EDV (RV-EDVi, 135.4 ml/m<sup>2</sup> vs. 104.7 ml/m<sup>2</sup>, <i>p</i> = 0.033) in the eaRHF group. ROC analysis identified CO (AUC = 0.90, sensitivity = 100%, specificity = 72%, <i>p</i> < 0.001), CI (AUC = 0.88, sensitivity = 83%, specificity = 83%, <i>p</i> < 0.001), and RV-SWI (AUC = 0.86, sensitivity = 83%, specificity = 86%, <i>p</i> < 0.001) as strong predictors. Moderate predictive values were observed for RV-EDVi (AUC = 0.73, <i>p</i> = 0.040) and RV global radial strain (RV-GRS; AUC = 0.70, <i>p</i> = 0.044).</p><p><strong>Conclusion: </strong>Hemodynamic parameters from RHC demonstrated the strongest predictive capability for eaRHF. However, selected CMR-derived parameters, especially indexed RV-EDV and RV GRS, offer moderate predictive value and may serve as adjunctive tools in preoperative risk stratification for LVAD candidates.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1629252"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12504228/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1629252","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Early acute right heart failure (eaRHF) during left ventricular assist device (LVAD) implantation significantly impacts patient survival and complicates perioperative management. Although numerous clinical, echocardiographic, and hemodynamic risk factors have been identified, accurately predicting eaRHF remains challenging. Cardiac magnetic resonance (CMR) provides a precise, non-invasive evaluation of cardiac structure and function and may enhance risk stratification eaRHF. This study aims to assess the predictive value of preoperative CMR-derived parameters, comparing their utility to established echocardiographic and right heart catheterization (RHC) markers for identifying eaRHF.

Methods: This retrospective analysis was conducted on 55 patients who received CMR before LVAD implantation at our center between 2018 and 2024. Of these 55 patients, 40 had image quality sufficient for offline analysis. Patients receiving a temporary right ventricular assist device (tRVAD) intraoperatively were defined as having eaRHF. Receiver Operating Characteristic (ROC) analysis was used to evaluate the predictive capability of CMR, echocardiographic, and RHC parameters.

Results: Ten patients (25%) developed eaRHF. Preoperative bilirubin levels were significantly higher in the eaRHF group (1.6 mg/dl vs. 1.1 mg/dl, p = 0.010). Echocardiographic Tricuspid Annular Plane Systolic Excursion (TAPSE) tended to be lower in eaRHF patients (12 mm vs. 18 mm, p = 0.080). RHC parameters, specifically right ventricular stroke work index (RV-SWI; p < 0.001), cardiac output (CO; p = 0.003), and cardiac index (CI; p = 0.004), were significantly lower in eaRHF patients. CMR showed significantly higher RV end-diastolic volumes (RV-EDV, 288.4 ml vs. 216.7 ml, p = 0.046) and indexed RV-EDV (RV-EDVi, 135.4 ml/m2 vs. 104.7 ml/m2, p = 0.033) in the eaRHF group. ROC analysis identified CO (AUC = 0.90, sensitivity = 100%, specificity = 72%, p < 0.001), CI (AUC = 0.88, sensitivity = 83%, specificity = 83%, p < 0.001), and RV-SWI (AUC = 0.86, sensitivity = 83%, specificity = 86%, p < 0.001) as strong predictors. Moderate predictive values were observed for RV-EDVi (AUC = 0.73, p = 0.040) and RV global radial strain (RV-GRS; AUC = 0.70, p = 0.044).

Conclusion: Hemodynamic parameters from RHC demonstrated the strongest predictive capability for eaRHF. However, selected CMR-derived parameters, especially indexed RV-EDV and RV GRS, offer moderate predictive value and may serve as adjunctive tools in preoperative risk stratification for LVAD candidates.

有和无早期急性右心衰患者在LVAD植入前心功能的比较分析:来自心脏磁共振的见解。
背景:左心室辅助装置(LVAD)植入术中早期急性右心衰(eaRHF)严重影响患者生存,并使围手术期处理复杂化。尽管已经确定了许多临床、超声心动图和血流动力学危险因素,但准确预测eaRHF仍然具有挑战性。心脏磁共振(CMR)提供了一种精确的、无创的心脏结构和功能评估,并可能增强eaRHF的风险分层。本研究旨在评估术前cmr衍生参数的预测价值,并将其与现有超声心动图和右心导管(RHC)标记物在识别eaRHF方面的效用进行比较。方法:回顾性分析2018年至2024年在我中心LVAD植入前接受CMR治疗的55例患者。在这55名患者中,40名患者的图像质量足以进行离线分析。术中使用临时右心室辅助装置(tRVAD)的患者被定义为eaRHF。采用受试者工作特征(ROC)分析评价CMR、超声心动图和RHC参数的预测能力。结果:10例(25%)发生eaRHF。术前胆红素水平在eaRHF组显著升高(1.6 mg/dl vs 1.1 mg/dl, p = 0.010)。超声心动图三尖瓣环状平面收缩偏移(TAPSE)在eaRHF患者中趋于较低(12 mm比18 mm, p = 0.080)。eaRHF患者的RHC参数,特别是右心室卒中工作指数(RV-SWI, p p = 0.003)和心脏指数(CI, p = 0.004)显著降低。CMR显示,eaRHF组左室舒张末期容积(RV- edv, 288.4 ml vs. 216.7 ml, p = 0.046)和指标RV- edv (RV- edvi, 135.4 ml/m2 vs. 104.7 ml/m2, p = 0.033)显著升高。ROC分析鉴定出CO (AUC = 0.90,灵敏度= 100%,特异性= 72%,p p p p = 0.040)和RV整体径向应变(RV- grs; AUC = 0.70, p = 0.044)。结论:RHC血流动力学参数对eaRHF的预测能力最强。然而,特定的cmr衍生参数,特别是索引RV- edv和RV GRS,提供了中等的预测价值,可以作为辅助工具,在术前LVAD候选人的风险分层。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信